Authors: WILCOX JN HARKER LA KELLY AB LUMSDEN AB CAREY KD OLLERENSHAW J WILLIS AL HANSON SR

Citation: Jn. Wilcox et al., INHIBITION OF VASCULAR LESION FORMATION IN THE NONHUMAN PRIMATE USINGA CHEMICALLY-MODIFIED HEPARIN DERIVATIVE, ASTENOSE(TM), Circulation, 90(4), 1994, pp. 296-296

Authors: WILCOX JN HARKER LA KELLY AB LUMSDEN AB CAREY KD OLLERENSHAW J WILLIS AL HANSON SR

Citation: Jn. Wilcox et al., INHIBITION OF VASCULAR LESION FORMATION IN THE NONHUMAN PRIMATE USINGA CHEMICALLY-MODIFIED HEPARIN DERIVATIVE, ASTENOSE(TM), Circulation, 90(4), 1994, pp. 296-296

Authors: WILLIS AL NI RX LOPEZ H YE H WU D GUZMAN B

Citation: Al. Willis et al., ANTITHROMBOTIC POTENTIAL OF ASTENOSE(TM) (GM1077) - A LOW ANTICOAGULANT HEPARIN AS EVALUATED IN MODEL SYSTEMS IN THE GUINEA-PIG, Thrombosis and haemostasis, 69(6), 1993, pp. 859-859

Authors: NI RX LOPEZ HW WILLIS AL

Citation: Rx. Ni et al., SUPPRESSION OF VWF-MEDIATED PLATELET-AGGREGATION BY ASTENOSE (GM1077), A LOW ANTI-COAGULANT HEPARIN, British Journal of Pharmacology, 109, 1993, pp. 160000067-160000067